- Visibility 37 Views
- Downloads 17 Downloads
- Permissions
- DOI 10.18231/j.ijpo.12113.1759303083
-
CrossMark
- Citation
Multifaceted central nervous system metastases: An analysis of the clinicopathologic spectrum
Background: Central nervous system (CNS) metastases are the most common causes of neurologic abnormalities in patients with systemic malignancies. They can often be the initial manifestations of an undetected primary elsewhere.
Materials and Methods: This is a retrospective study which included 55 patients diagnosed with either brain or spinal cord metastases. The study period was four years. The cases were classified based on histopathology and immunohistochemistry was performed in cases of metastases from unknown primary. Primary CNS tumors were excluded from the study.
Results: In the study period, a total of 169 CNS neoplasms were diagnosed, including 114 (67.5%) primary and 55 (32.5%) secondary tumors. Most of the patients were in the 5th-6th decade of life, with a male preponderance (M:F ratio of 2.6:1). The most common site for metastases in CNS was cerebrum (n=30, 54.5%) followed by spinal cord (n=19, 34.5%) and cerebellum (n=6, 11%) respectively. The most common histological type was adenocarcinoma (65.4%) followed by poorly differentiated carcinoma (20.1%) and squamous cell carcinoma (12.1%). Primary sites could be detected in 48 cases (71.8%). The most common site of primary malignancy was lung (n=16, 29%) followed by kidney (n=7, 12.7%) and prostate (n=6; 10.9%). Two unusual cases with metastatic urothelial carcinoma were identified.
Conclusion: Metastatic tumors of brain and spinal cord are a major cause of morbidity and mortality and may pose a diagnostic difficulty on clinical and radiological examination. Histopathologic examination with the aid of immunohistochemistry is of utmost importance to render the correct diagnosis.
References
- Wang G, Xu J, Qi Y, Xiu J, Li R, Han M. Distribution Of Brain Metastasis From Lung Cancer. Cancer Manag Res. 2019;11:9331–
- https://doi.org/10.2147/CMAR.S222920
[Google Scholar] - Singh S, Amirtham U, Premalata CS, Lakshmaiah KC, Viswanath L, Kumar RV. Spectrum of metastatic neoplasms of the brain: A clinicopathological study in a tertiary care cancer centre. Neurol India. 2018;66(3):733–8. https://doi.org/10.4103/0028-3886.232333
[Google Scholar] - Zuccato JA, O’Halloran PJ, Zadeh G. A review of Central Nervous System Metastases: Diagnosis and Treatment, First Edition, 2020. Neurooncol Adv. 2020;2(1):vdaa102. https://doi.org/10.1093/noajnl/vdaa102
[Google Scholar] - Fox BD, Cheung VJ, Patel AJ, Suki D, Rao G. Epidemiology of metastatic brain tumors. Neurosurg Clin N Am. 2011;22(1):1–6. https://doi.org/10.1016/j.nec.2010.08.007
[Google Scholar] - Laakmann E, Witzel I, Fasching PA, Rezai M, Schem C, Solbach C, et al. Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto. Breast Cancer Res. 2019;21(1):60. https://doi.org/10.1186/s13058-019-1144-x
[Google Scholar] - Boire A, Brastianos PK, Garzia L, Valiente M. Brain metastasis. Nat Rev Cancer. 2020;20(1):4–11. https://doi.org/10.1038/s41568-019-
[Google Scholar] 0220-y. - Gupta A, Chaturvedi S, Jha D, Chaturvedi M. Revisiting metastatic central nervous system tumors with unknown primary using clinicopathological findings: A single neurosciences institutional study. Indian J Pathol Microbiol. 2019;62(3):368–74. https://doi.org/10.4103/IJPM.IJPM_592_18
[Google Scholar] - Tas Z, Kulahci O. Histopathological Analysis of Central Nervous System Metastases: Six Years of Data From a Tertiary Center. Cureus. 2022;14(2):e22151. https://doi.org/10.7759/cureus.22151
[Google Scholar] - Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol. 2005;75(1):5–14. https://doi.org/10.1007/s11060-004-8093-6
[Google Scholar] - Salvati M, Frati A, Russo N, Brogna C, Piccirilli M, D'Andrea G, et al. Brain metastasis from prostate cancer. Report of 13 cases and critical analysis of the literature. J Exp Clin Cancer Res. 2005;24(2):203–7.
- Nathoo N, Chahlavi A, Barnett GH, Toms SA. Pathobiology of brain metastases. J Clin Pathol. 2005;58(3):237–42. https://doi.org/10.1136/jcp.2003.013623
[Google Scholar] - Gerrard GE, Franks KN. Overview of the diagnosis and management of brain, spine, and meningeal metastases. J Neurol Neurosurg Psychiatry. 2004;75 Suppl 2(Suppl 2):ii37–42. https://doi.org/10.1136/jnnp.2004.040493
[Google Scholar] - Mut M, Schiff D, Shaffrey ME. Metastasis to nervous system: spinal epidural and intramedullary metastases. J Neurooncol. 2005;75(1):43–56. https://doi.org/10.1007/s11060-004-8097-2
[Google Scholar] - Shah LM, Salzman KL. Imaging of spinal metastatic disease. Int J Surg Oncol. 2011;2011:769753. https://doi.org/10.1155/2011/769753
[Google Scholar] - Pekmezci M, Perry A. Neuropathology of brain metastases. Surg Neurol Int. 2013;4(Suppl 4):S245–55. https://doi.org/10.4103/2152-7806.111302
[Google Scholar] - Li L, Luo S, Lin H, Yang H, Chen H, Liao Z, et al. Correlation between EGFR mutation status and the incidence of brain metastases in patients with non-small cell lung cancer. J Thorac Dis. 2017;9(8):2510–20. https://doi.org/10.21037/jtd.2017.07.57
[Google Scholar] - Zhao W, Zhou W, Rong L, Sun M, Lin X, Wang L, et al. Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer. Front Oncol. 2022;12:912505. https://doi.org/10.3389/fonc.2022.912505
[Google Scholar] - D'Antonio C, Passaro A, Gori B, Del Signore E, Migliorino MR, Ricciardi S, et al. Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies. Ther Adv Med Oncol. 2014;6(3):101–14. https://doi.org/10.1177/1758834014521110
[Google Scholar] - Ke ZB, Chen SH, Chen YH, Wu YP, Lin F, Xue XY, et al. Risk Factors for Brain Metastases in Patients with Renal Cell Carcinoma. Biomed Res Int. 2020;2020:6836234. https://doi.org/10.1155/2020/6836234
[Google Scholar] - Lee CC, Tey JCS, Cheo T, Lee CH, Wong A, Kumar N, et al. Outcomes of patients with spinal metastases from renal cell carcinoma treated with conventionally-fractionated external beam radiation therapy. Medicine (Baltimore). 2020;99(16):e19838. https://doi.org/10.1097/MD.0000000000019838
[Google Scholar] - Wyler L, Napoli CU, Ingold B, Sulser T, Heikenwälder M, Schraml P, et al. Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression. Br J Cancer. 2014;110(3):686–94. https://doi.org/10.1038/bjc.2013.755
[Google Scholar] - Watase C, Shiino S, Shimoi T, Noguchi E, Kaneda T, Yamamoto Y, et al. Breast Cancer Brain Metastasis-Overview of Disease State, Treatment Options and Future Perspectives. Cancers (Basel). 2021;13(5):1078. https://doi.org/10.3390/cancers13051078
[Google Scholar] - Alhalabi O, Soomro Z, Sun R, Hasanov E, Albittar A, Tripathy D, et al. Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases. NPJ Breast Cancer. 2021;7(1):28. https://doi.org/10.1038/s41523-021-00235-
[Google Scholar] - 246 Kaur et al. / Indian Journal of Pathology and Oncology 2025;12(3):241–246
- Leone JP, Leone BA. Breast cancer brain metastases: the last frontier. Exp Hematol Oncol. 2015;4:33. https://doi.org/10.1186/s40164-015-0028-8
[Google Scholar] - Brenneman RJ, Gay HA, Christodouleas JP, Sargos P, Arora V, Fischer-Valuck B, et al. Review: Brain metastases in bladder cancer. Bladder Cancer. 2020;6(3):237–48. https://doi.org/10.3233/BLC-
[Google Scholar] - Jain T, Gupta S, Robinette N, Shi D, Vaishampayan UN. Urothelial Carcinoma with Intracranial Lesion: Metastasis or Abscess? Clin Med Rev Case Rep. 2018;5:203. https://doi.org/10.23937/2378-
[Google Scholar] 3656/1410203. - Fang W-K, Jou YC, Dai YC, Ko PC, Huang YF. Brain metastasis from renal urothelial carcinoma successfully treated by metastasectomy. Tzu Chi Med J. 2018;30(1):41–3. https://doi.org/10.4103/tcmj.tcmj_82_17
[Google Scholar]
How to Cite This Article
Vancouver
Kaur M, Punia R, Sharma P, Bhagat R, Aggarwal P, Handa U, Gupta V. Multifaceted central nervous system metastases: An analysis of the clinicopathologic spectrum [Internet]. Indian J Pathol Oncol. 2025 [cited 2025 Oct 20];12(3):241-246. Available from: https://doi.org/10.18231/j.ijpo.12113.1759303083
APA
Kaur, M., Punia, R., Sharma, P., Bhagat, R., Aggarwal, P., Handa, U., Gupta, V. (2025). Multifaceted central nervous system metastases: An analysis of the clinicopathologic spectrum. Indian J Pathol Oncol, 12(3), 241-246. https://doi.org/10.18231/j.ijpo.12113.1759303083
MLA
Kaur, Manveen, Punia, RPS, Sharma, Pooja, Bhagat, Ranjeev, Aggarwal, Phiza, Handa, Uma, Gupta, Vipin. "Multifaceted central nervous system metastases: An analysis of the clinicopathologic spectrum." Indian J Pathol Oncol, vol. 12, no. 3, 2025, pp. 241-246. https://doi.org/10.18231/j.ijpo.12113.1759303083
Chicago
Kaur, M., Punia, R., Sharma, P., Bhagat, R., Aggarwal, P., Handa, U., Gupta, V.. "Multifaceted central nervous system metastases: An analysis of the clinicopathologic spectrum." Indian J Pathol Oncol 12, no. 3 (2025): 241-246. https://doi.org/10.18231/j.ijpo.12113.1759303083